Jonathan B. Siegel, Director at Jaguar Health, Inc. (JAGX), bought 25,000 shares at $0.60 ($15K) on 2018-10-04, disclosed to the SEC on 2018-10-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| JAGX | BUY | 2018-07-20 | $6K | — | Filing → |
| JAGX | BUY | 2018-07-18 | $13K | — | Filing → |